Adlai Nortye (ANL) Total Debt (2022 - 2025)
Adlai Nortye's (ANL) quarterly Total Debt came in at $24.6 million in Q4 2025, down 6.64% year-on-year from $26.3 million in Q4 2024, and down 6.64% on a QoQ basis from $26.3 million in Q4 2024.
Adlai Nortye (ANL) Total Debt (2022 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 4 years of Total Debt data on file, last reported at $24.6 million in Q4 2025.
- On a quarterly basis, Total Debt fell 6.64% year-over-year to $24.6 million in Q4 2025; TTM through Dec 2025 was $24.6 million, a 6.64% decrease from a year earlier, with the FY2025 full-year figure at $24.6 million, down 6.64% from the prior year.
- Total Debt for Q4 2025 stood at $24.6 million, down from $26.3 million in the prior quarter.
- Over the last five years, Total Debt for ANL reached as high as $30.4 million in Q4 2023 and fell as low as $4.3 million in Q4 2022.
- Historically, Total Debt has averaged $21.4 million across 4 years, with a median of $25.5 million in 2024.
- Across the five-year window, Total Debt jumped 604.83% in 2023 and dropped 13.27% in 2024, its largest moves.
- Year by year, Total Debt stood at $4.3 million in 2022, then soared by 604.83% to $30.4 million in 2023, then decreased by 13.27% to $26.3 million in 2024, then fell by 6.64% to $24.6 million in 2025.
- Per Business Quant data, the three most recent Total Debt figures were $24.6 million in Q4 2025, $26.3 million in Q4 2024, and $30.4 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 959.06 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 24.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.58 Mn |
| Dec 31, 2024 | 26.33 Mn |
| Dec 31, 2023 | 30.36 Mn |
| Dec 31, 2022 | 4.31 Mn |